Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baker Young is an Australian independent stockbroking and wealth management firm that maintains a specialized focus on the life sciences and biotechnology sectors. Headquartered in Adelaide, the company provides corporate advisory, capital raising, and portfolio management services to both institutional and private clients. While not a drug developer itself, Baker Young is a prominent player in the Australian biotech ecosystem, frequently acting as a lead manager for ASX-listed healthcare companies during IPOs and secondary capital raisings. The firm also manages the Baker Young Life Sciences Fund, which targets high-growth opportunities in medical technology, diagnostics, and therapeutics. Through its dedicated research and advisory arms, Baker Young supports the commercialization of emerging medical innovations by connecting them with necessary capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baker Young.